Completed PHASE4 INTERVENTIONAL 1-arm NCT01245322

Treatment of Bacterial Vaginosis Combined With Human Lactobacilli

Extended Antimicrobial Treatment of Bacterial Vaginosis Combined With Human Lactobacilli to Find the Best Treatment and Minimize the Risk of Relapses

Sponsor: Karolinska University Hospital

Conditions Bacterial Vaginosis

Interventions lactobacilli

Updated 6 times since 2017 Last updated: Nov 6, 2014 Started: Jan 31, 2007 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Bacterial Vaginosis, this trial is completed. The trial is conducted by Karolinska University Hospital and has accumulated 6 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska University Hospital
Skaraborg Hospital

Data source: Skaraborg Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Drammen, Norway